Accredo is a specialized medical app for patients with chronic conditions, acting as a digital portal for Accredo Health Group's specialty pharmacy services. It differentiates itself through condition-specific clinical support (TRCs) and robust copay assistance tools. While it maintains a high user rating of 4.8 on iOS, it faces significant competition from CVS Specialty's retail ecosystem and digital-first disruptors like Alto Pharmacy.
Product velocity
Unknown
Daily rank 🇺🇸
#91
▲2Medical · free
Sentiment
4.8
63k reviews
Nemesis
CVS Specialty
The App DNA
What makes this app unique?
For Patients managing complex or chronic conditions such as cancer, multiple sclerosis, HIV, or bleeding disorders who require specialized pharmacy support.
What does it look like?
Key features
Digital portal for ordering refills and tracking specialty medication orders
Access to condition-specific clinical teams including pharmacists and infusion nurses
Searchable tool to find financial support programs tailored to specific medications
In-app notifications to help patients adhere to their medication schedules
How much does it cost?
The app is a value-added service designed to drive patient adherence and operational efficiency for the pharmacy, rather than generating direct revenue.
Velocity
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans excited. Users appreciate ease of use and convenience and responsive customer service, but report order processing and delivery issues.
How are ratings & reviews evolving?
What users say, by theme
- Ease of Use and Convenience
- Responsive Customer Service
Unlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Accredo
How's the Medical market?
The rivals identified
By CVS Health
The most direct market rival, serving as the specialty pharmacy arm for the largest pharmacy chain and PBM (Caremark) in the U.S.
- Seamless integration with CVS Pharmacy retail locations for pickup and consultations
- Direct linkage with Aetna insurance plans for streamlined approvals
- Secure messaging feature for direct communication with specialty care teams
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Accredo
Where is it heading?
- Last updated April 2026 with enhanced copay tools — indicates active feature investment, not maintenance mode.
- High rating (4.8) but stable ranking (#88) — suggests strong retention of existing users but limited aggressive growth.
- Persistent complaints about order cancellations — indicates a disconnect between digital UX and physical fulfillment.
The SWOT
- High user sentiment and stable mobile experience (4.8 rating)
- Condition-specific clinical specialization via TRCs
- Robust in-app copay assistance navigation tools
- Implement real-time courier tracking to match Alto Pharmacy
- Add in-app secure messaging with specialty care teams (Nemesis feature)
- Expand to a full 'Medicine Cabinet' view for all patient medications
Next best moves
Audit and fix backend data synchronization for order status
+ 2 more prioritized movesFeature gaps
Retail pickup integration (available in CVS Specialty) +3
Bottom line
Accredo is the clinical leader in the specialty pharmacy app space, outperforming CVS Specialty in user satisfaction. However, it faces a critical risk from backend data discrepancies that lead to unexpected order cancellations, a failure point that digital-first competitors like Alto are exploiting with superior delivery transparency.
Unlock 3 critical frictions, 3 market threats, 2 more prioritized moves and the analyst’s take.
Access the full report for freeReport last updated